Characteristics | n (%) |
---|---|
Sex | |
Male | 3 (6) |
Female | 49 (94) |
Ethnicity | |
White | 24 (46) |
African American | 23 (44) |
Other | 5 (10) |
Age, yrs | |
< 30 | 13 (25) |
30–44 | 16 (31) |
45–59 | 16 (31) |
60+ | 7 (13) |
Duration of SLE at first assessment, yrs | |
< 2 | 19 (37) |
2–5 | 18 (35) |
5+ | 15 (29) |
No. visits | |
3 | 1 (2) |
4 | 43 (83) |
5+ | 8 (15) |
Treated with prednisone 10 mg/day or more | |
No visits | 1 (2) |
Some visits | 43 (83) |
All visits | 8 (15) |
HCQ therapy | |
No visits | 14 (27) |
Some visits | 10 (19) |
All visits | 28 (54) |
History of diabetes | 3 (6) |
History of hypertension | 10 (19) |
SLE: systemic lupus erythematosus; HCQ: hydroxychloroquine.